Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Retained Earnings (2016 - 2025)

Acro Biomedical (ACBM) has 10 years of Retained Earnings data on record, last reported at -$32.8 million in Q4 2025.

  • For Q4 2025, Retained Earnings changed 0.31% year-over-year to -$32.8 million; the TTM value through Dec 2025 reached -$32.8 million, changed 0.31%, while the annual FY2025 figure was -$32.8 million, 0.31% changed from the prior year.
  • Retained Earnings reached -$32.8 million in Q4 2025 per ACBM's latest filing, roughly flat from -$32.8 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$298148.0 in Q1 2021 and bottomed at -$32.8 million in Q3 2025.
  • Average Retained Earnings over 5 years is -$23.5 million, with a median of -$31.8 million recorded in 2023.
  • Peak YoY movement for Retained Earnings: crashed 3879.66% in 2022, then fell 0.13% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$7.9 million in 2021, then tumbled by 199.98% to -$23.8 million in 2022, then tumbled by 36.99% to -$32.6 million in 2023, then decreased by 0.13% to -$32.7 million in 2024, then decreased by 0.31% to -$32.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were -$32.8 million in Q4 2025, -$32.8 million in Q3 2025, and -$32.7 million in Q2 2025.